Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Comunicato Precedente
Comunicato Successivo
COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company's shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
1. | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | Paul John Chaplin | |
2. | Reason for the notification | ||
a) | Position/status | President and Chief Executive Officer of Bavarian Nordic A/S | |
b) | Initial notification/Amendment | Initial notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Bavarian Nordic A/S | |
b) | LEI | 2138006JCDVYIN6INP51 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code |
Shares DK0015998017 |
|
b) | Nature of the transaction | Exercise of warrants | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
DKK 146.60 | 98,855 | ||
d) | Aggregated information
|
98,855 DKK 14,492,143.00 |
|
e) | Date of the transaction | 2024-09-05 | |
f) | Place of the transaction | Nasdaq Copenhagen A/S, XCSE |
1. | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | Henrik Juuel | |
2. | Reason for the notification | ||
a) | Position/status | Executive Vice President and Chief Financial Officer of Bavarian Nordic A/S | |
b) | Initial notification/Amendment | Initial notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Bavarian Nordic A/S | |
b) | LEI | 2138006JCDVYIN6INP51 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code |
Shares DK0015998017 |
|
b) | Nature of the transaction | Exercise of warrants | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
DKK 146.60 | 42,916 | ||
d) | Aggregated information
|
42,916 DKK 6,291,486.00 |
|
e) | Date of the transaction | 2024-09-05 | |
f) | Place of the transaction | Nasdaq Copenhagen A/S, XCSE |
1. | Details of the person discharging managerial responsibilities/person closely associated | ||
a) | Name | Jean-Christophe May | |
2. | Reason for the notification | ||
a) | Position/status | Executive Vice President and Chief Commercial Officer of Bavarian Nordic A/S | |
b) | Initial notification/Amendment | Initial notification | |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Bavarian Nordic A/S | |
b) | LEI | 2138006JCDVYIN6INP51 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code |
Shares DK0015998017 |
|
b) | Nature of the transaction | Exercise of warrants | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
DKK 155.80 | 7,039 | ||
d) | Aggregated information
|
7,039 DKK 1,096,676.00 |
|
e) | Date of the transaction | 2024-09-05 | |
f) | Place of the transaction | Nasdaq Copenhagen A/S, XCSE |
About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines. We are a global leader in smallpox and mpox vaccines, supplied to governments to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit
www.bavarian-nordic.com.
Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations,
[email protected], Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors,
[email protected], Tel: +1 781 686 9600
Company Announcement no. 28 / 2024
Attachment
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti